Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

• Unité de recherche: INNOSUISSE
• Numéro de projet: 19310.1 PFLS-LS
• Titre du projet anglais: Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Description succincte (Allemand)

Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Description succincte (Anglais)

Discovery & development of novel peptide drug conjugates for the treatment of acute myeloid leukemia

Résumé des résultats (Abstract) (Allemand)

To develop novel peptide drug conjugates that target a newly identified cancer marker overexpressed in multiple cancers. The project aims to create peptide drug conjugates for treating acute myeloid leukemia and obtain at least one drug candidate ready for further development. This will enable Phi Pharma to secure additional financing to prepare for the first clinical trial, and eventually enter into a significant collaboration with a major pharmaceutical company.

Résumé des résultats (Abstract) (Anglais)